Galderma Launches Two New Dermal Fillers

In December, Galderma received FDA approval for a pair of next-generation hyaluronic acid (HA) dermal fillers: Restylane Refyne and Restylane Defyne.
“Refyne was approved for the treatment of moderate to severe facial wrinkles and folds, such as the nasolabial folds, in patients over the age of 21,” Mitchel P. Goldman, M.D., a volunteer clinical professor of dermatology at the University of California, San Diego, tells Cosmetic Surgery Times.
Dr. Goldman says Refyne is a unique gel filler designed with XpresHAn Technology, “which allows for flexibility and support. It also provides options for individuals who crave natural-looking results that allow for natural expression and every day motion.”
Dr. Goldman is excited to offer Refyne to patients who are looking to address their “smile and laugh lines.”
Defyne was approved for the same indications and minimum patient age. It also incorporates XpresHAn Technology, “although the filler provides a higher level of support for deeper lines,” Dr. Goldman says. 
Both products achieve natural-looking results and help to maintain expressions in motion, along with “a long-standing history of proven safety and efficacy,” Dr. Goldman says.
Read more at Cosmetic Surgery Times >>